VTEX (VTEX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
02-26

For the quarter ended December 2024, VTEX (VTEX) reported revenue of $61.52 million, up 1.3% over the same period last year. EPS came in at $0.03, compared to $0.02 in the year-ago quarter.

The reported revenue represents a surprise of -3.00% over the Zacks Consensus Estimate of $63.43 million. With the consensus EPS estimate being $0.05, the EPS surprise was -40.00%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how VTEX performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • GMV: $5.39 billion versus $5.65 billion estimated by two analysts on average.
  • Revenue- Services revenue: $2.06 million compared to the $2 million average estimate based on two analysts. The reported number represents a change of -17.4% year over year.
  • Revenue- Subscription revenue: $59.46 million compared to the $61.43 million average estimate based on two analysts. The reported number represents a change of +2.1% year over year.
View all Key Company Metrics for VTEX here>>>

Shares of VTEX have returned -0.8% over the past month versus the Zacks S&P 500 composite's -1.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

VTEX (VTEX) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10